Status:
COMPLETED
Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence
Lead Sponsor:
Allergan
Conditions:
Eyelashes
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study evaluates the safety and effectiveness of topical bimatoprost solution for enhancing eyelash prominence.
Eligibility Criteria
Inclusion
- Dissatisfaction with eyelash prominence,
- Eyelash prominence assessment of minimal or moderate,
- Ability to provide written informed consent
Exclusion
- Subjects without visible lashes,
- Asymmetrical (uneven lashes or longer on one side than the other) eyelashes,
- Any eye disease or abnormality,
- Eye surgery,
- Permanent eyeliner,
- Eyelash implants,
- Eyelash extension application,
- Any use of eyelash growth products within 6 months of study entry,
- Treatments that may effect hair growth,
- Subjects requiring eye drop medications for glaucoma,
- Subjects having a situation or condition, which the study doctor feels might put you at risk, may make the study results confusing, or may interfere with the study.
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
278 Patients enrolled
Trial Details
Trial ID
NCT00693420
Start Date
April 1 2007
End Date
December 1 2007
Last Update
October 30 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
San Diego, California, United States
2
Vancouver, British Columbia, Canada